speb/financial-data huggingface dataset:
CPRX balance_sheet (annual, 2025-12-31) — Current Liabilities: 147152000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 147152000.00
CPRX cash_flow (annual, 2025-12-31) — Deferred Income Tax: -6849000.00
CPRX cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -4511000.00
CPRX cash_flow (annual, 2025-12-31) — Deferred Tax: -6849000.00
CPRX cash_flow (quarterly, 2025-12-31) — Deferred Tax: -4511000.00
CPRX cash_flow (annual, 2025-12-31) — Depreciation: 375000.00
CPRX cash_flow (quarterly, 2025-12-31) — Depreciation: 72000.00
CPRX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 37873000.00
CPRX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 9537000.00
CPRX income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 37498000.00
CPRX income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 9465000.00
CPRX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 37873000.00
CPRX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 9537000.00
CPRX income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 37498000.00
CPRX income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 9465000.00
CPRX income_statement (annual, 2025-12-31) — Diluted Average Shares: 127257929.00
CPRX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 127425644.00
CPRX income_statement (annual, 2025-12-31) — Diluted EPS: 1.68
CPRX income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.41
CPRX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 214326000.00
CPRX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 52698000.00
CPRX income_statement (annual, 2025-12-31) — EBIT: 257778000.00
CPRX income_statement (quarterly, 2025-12-31) — EBIT: 61846000.00
CPRX income_statement (annual, 2025-12-31) — EBITDA: 295651000.00
CPRX income_statement (quarterly, 2025-12-31) — EBITDA: 71383000.00
CPRX cash_flow (annual, 2025-12-31) — End Cash Position: 709171000.00
CPRX cash_flow (quarterly, 2025-12-31) — End Cash Position: 709171000.00
CPRX cash_flow (annual, 2025-12-31) — Financing Cash Flow: -16994000.00
CPRX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -25580000.00
CPRX balance_sheet (annual, 2025-12-31) — Finished Goods: 16158000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Finished Goods: 16158000.00
CPRX cash_flow (annual, 2025-12-31) — Free Cash Flow: 208612000.00
CPRX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 44859000.00
CPRX income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 972000.00
CPRX income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 3369000.00
CPRX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
CPRX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
CPRX income_statement (annual, 2025-12-31) — General And Administrative Expense: 71511000.00
CPRX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 19823000.00
CPRX balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 131674000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 131674000.00
CPRX balance_sheet (annual, 2025-12-31) — Gross PPE: 4467000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 4467000.00
CPRX income_statement (annual, 2025-12-31) — Gross Profit: 501736000.00
CPRX income_statement (quarterly, 2025-12-31) — Gross Profit: 126539000.00
CPRX cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 71986000.00
CPRX cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 16851000.00
CPRX balance_sheet (annual, 2025-12-31) — Income Tax Payable: 1396000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 1396000.00
CPRX cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 466000.00
CPRX cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 130000.00
CPRX balance_sheet (annual, 2025-12-31) — Interest Payable: 135000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Interest Payable: 135000.00
CPRX balance_sheet (annual, 2025-12-31) — Inventory: 37166000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Inventory: 37166000.00
CPRX balance_sheet (annual, 2025-12-31) — Invested Capital: 954268000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 954268000.00
CPRX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -58000.00
CPRX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -32000.00
CPRX balance_sheet (annual, 2025-12-31) — Investments And Advances: 22536000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 22536000.00
CPRX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
CPRX cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CPRX balance_sheet (annual, 2025-12-31) — Leases: 991000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Leases: 991000.00
CPRX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 2350000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 2350000.00
CPRX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2350000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2350000.00
CPRX balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 22536000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 22536000.00
CPRX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1541000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1541000.00
CPRX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -25300000.00
CPRX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -25300000.00
CPRX income_statement (annual, 2025-12-31) — Net Income: 214326000.00
CPRX income_statement (quarterly, 2025-12-31) — Net Income: 52698000.00
CPRX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 214326000.00
CPRX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 52698000.00
CPRX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 214326000.00
CPRX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 52698000.00
CPRX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 214326000.00
CPRX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 52698000.00
CPRX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 214326000.00
CPRX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 52698000.00
CPRX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 214326000.00
CPRX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 52698000.00
CPRX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 214326000.00
CPRX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 52698000.00
CPRX cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: 0.00
CPRX income_statement (annual, 2025-12-31) — Net Interest Income: 24765000.00
CPRX income_statement (quarterly, 2025-12-31) — Net Interest Income: 6686000.00
CPRX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 0.00
CPRX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 24765000.00
CPRX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 6686000.00
CPRX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -6363000.00
CPRX cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -2156000.00
CPRX balance_sheet (annual, 2025-12-31) — Net PPE: 2972000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Net PPE: 2972000.00
CPRX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -58000.00
CPRX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -32000.00
CPRX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 822594000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 822594000.00
CPRX balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 52767000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 52767000.00
CPRX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 52767000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 52767000.00
CPRX income_statement (annual, 2025-12-31) — Normalized EBITDA: 294679000.00
CPRX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 68014000.00
CPRX income_statement (annual, 2025-12-31) — Normalized Income: 213591168.00
CPRX income_statement (quarterly, 2025-12-31) — Normalized Income: 50228777.57
CPRX cash_flow (annual, 2025-12-31) — Operating Cash Flow: 208670000.00
CPRX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 44891000.00
CPRX income_statement (annual, 2025-12-31) — Operating Income: 257778000.00
CPRX income_statement (quarterly, 2025-12-31) — Operating Income: 61846000.00
CPRX income_statement (annual, 2025-12-31) — Operating Revenue: 588989000.00
CPRX income_statement (quarterly, 2025-12-31) — Operating Revenue: 152613000.00
CPRX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 122513621.00
CPRX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 122513621.00
CPRX balance_sheet (annual, 2025-12-31) — Other Current Assets: 19427000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 19427000.00
CPRX balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 840000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 840000.00
CPRX income_statement (annual, 2025-12-31) — Other Gand A: 48938000.00
CPRX income_statement (quarterly, 2025-12-31) — Other Gand A: 14628000.00
CPRX income_statement (annual, 2025-12-31) — Other Income Expense: 972000.00
CPRX income_statement (quarterly, 2025-12-31) — Other Income Expense: 3369000.00
CPRX balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 131674000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 131674000.00
CPRX cash_flow (annual, 2025-12-31) — Other Non Cash Items: -55000.00
CPRX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -41000.00
CPRX balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 209000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 209000.00
CPRX balance_sheet (annual, 2025-12-31) — Other Payable: 13799000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Other Payable: 13799000.00
CPRX balance_sheet (annual, 2025-12-31) — Other Properties: 1935000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Other Properties: 1935000.00
CPRX balance_sheet (annual, 2025-12-31) — Payables: 26397000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Payables: 26397000.00
CPRX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 134517000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 134517000.00
CPRX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 11358000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 11358000.00
CPRX balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CPRX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CPRX income_statement (annual, 2025-12-31) — Pretax Income: 283515000.00
CPRX income_statement (quarterly, 2025-12-31) — Pretax Income: 71901000.00
CPRX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 14669000.00
CPRX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 1876000.00
CPRX balance_sheet (annual, 2025-12-31) — Properties: 0.00
CPRX balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CPRX cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: 0.00
CPRX cash_flow (annual, 2025-12-31) — Purchase Of Investment: 0.00
CPRX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -58000.00
CPRX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -32000.00
CPRX balance_sheet (annual, 2025-12-31) — Raw Materials: 17137000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Raw Materials: 17137000.00
CPRX balance_sheet (annual, 2025-12-31) — Receivables: 128266000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Receivables: 128266000.00
CPRX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 86878000.00
CPRX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 26002000.00
CPRX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 37873000.00
CPRX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 9537000.00
CPRX cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -25300000.00
CPRX cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -25300000.00
CPRX income_statement (annual, 2025-12-31) — Research And Development: 12709000.00
CPRX income_statement (quarterly, 2025-12-31) — Research And Development: 1807000.00
CPRX balance_sheet (annual, 2025-12-31) — Retained Earnings: 474188000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 474188000.00
CPRX income_statement (annual, 2025-12-31) — Salaries And Wages: 22573000.00
CPRX income_statement (quarterly, 2025-12-31) — Salaries And Wages: 5195000.00
CPRX income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 122240000.00
CPRX income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 33598000.00
CPRX income_statement (annual, 2025-12-31) — Selling General And Administration: 193751000.00
CPRX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 53421000.00
CPRX balance_sheet (annual, 2025-12-31) — Share Issued: 122513621.00
CPRX balance_sheet (quarterly, 2025-12-31) — Share Issued: 122513621.00
CPRX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 24778000.00
CPRX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 5661000.00
CPRX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 954268000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 954268000.00
CPRX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 822594000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 822594000.00
CPRX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 237168.00
CPRX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 899777.57
CPRX income_statement (annual, 2025-12-31) — Tax Provision: 69189000.00
CPRX income_statement (quarterly, 2025-12-31) — Tax Provision: 19203000.00
CPRX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.24
CPRX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.27
CPRX balance_sheet (annual, 2025-12-31) — Total Assets: 1103979000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Total Assets: 1103979000.00
CPRX balance_sheet (annual, 2025-12-31) — Total Capitalization: 954268000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 954268000.00
CPRX balance_sheet (annual, 2025-12-31) — Total Debt: 2787000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Total Debt: 2787000.00
CPRX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 954268000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 954268000.00
CPRX income_statement (annual, 2025-12-31) — Total Expenses: 331211000.00
CPRX income_statement (quarterly, 2025-12-31) — Total Expenses: 90767000.00
CPRX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 149711000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 149711000.00
CPRX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 209949000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 209949000.00
CPRX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2559000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2559000.00
CPRX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 257778000.00
CPRX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 61846000.00
CPRX income_statement (annual, 2025-12-31) — Total Other Finance Cost: -24765000.00
CPRX balance_sheet (annual, 2025-12-31) — Total Tax Payable: 1396000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 1396000.00
CPRX income_statement (annual, 2025-12-31) — Total Unusual Items: 972000.00
CPRX income_statement (quarterly, 2025-12-31) — Total Unusual Items: 3369000.00
CPRX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 972000.00
CPRX income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 3369000.00
CPRX cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -972000.00
CPRX cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -3369000.00
CPRX balance_sheet (annual, 2025-12-31) — Work In Process: 3871000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Work In Process: 3871000.00
CPRX balance_sheet (annual, 2025-12-31) — Working Capital: 746878000.00
CPRX balance_sheet (quarterly, 2025-12-31) — Working Capital: 746878000.00
CPRX income_statement (quarterly, 2026-03-31) — +Operating Expense: 61683000.00
CPRX income_statement (quarterly, 2026-03-31) — +Total Revenue: 149390000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 7151000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 130834000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Accrued Interest Receivable: 472000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -1565000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 489218000.00
CPRX income_statement (quarterly, 2026-03-31) — Amortization: 9703000.00
CPRX cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 9703000.00
CPRX cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 9703000.00
CPRX income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 9703000.00
CPRX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 122254171.00
CPRX income_statement (quarterly, 2026-03-31) — Basic EPS: 0.52
CPRX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 709171000.00
CPRX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -27000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 2681000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 122000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 755859000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 755859000.00
CPRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -12872000.00
CPRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -27000.00
CPRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 59587000.00
CPRX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -4051000.00
CPRX cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -9207000.00
CPRX cash_flow (quarterly, 2026-03-31) — Change In Inventory: 2236000.00
CPRX cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -106000.00
CPRX cash_flow (quarterly, 2026-03-31) — Change In Payable: -4051000.00
CPRX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -13258000.00
CPRX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 2449000.00
CPRX cash_flow (quarterly, 2026-03-31) — Change In Receivables: -4357000.00
CPRX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -13036000.00
CPRX cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -4357000.00
CPRX cash_flow (quarterly, 2026-03-31) — Changes In Cash: 46688000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Common Stock: 122000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1012697000.00
CPRX cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -14574000.00
CPRX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 14475000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 95472000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Current Assets: 940390000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 446000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 446000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 132398000.00
CPRX cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -2336000.00
CPRX cash_flow (quarterly, 2026-03-31) — Deferred Tax: -2336000.00
CPRX cash_flow (quarterly, 2026-03-31) — Depreciation: 70000.00
CPRX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 9773000.00
CPRX income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 9703000.00
CPRX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 9773000.00
CPRX income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 9703000.00
CPRX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 126903391.00
CPRX income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.50
CPRX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 63734000.00
CPRX income_statement (quarterly, 2026-03-31) — EBIT: 73232000.00
CPRX income_statement (quarterly, 2026-03-31) — EBITDA: 83005000.00
CPRX cash_flow (quarterly, 2026-03-31) — End Cash Position: 755859000.00
CPRX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -12872000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Finished Goods: 15281000.00
CPRX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 59560000.00
CPRX income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 4750000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 8000.00
CPRX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 19658000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 121971000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 4417000.00
CPRX income_statement (quarterly, 2026-03-31) — Gross Profit: 134915000.00
CPRX cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 1839000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 19626000.00
CPRX income_statement (quarterly, 2026-03-31) — Interest Income: 6247000.00
CPRX income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 6247000.00
CPRX cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 140000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Interest Payable: 0.00
CPRX balance_sheet (quarterly, 2026-03-31) — Inventory: 34930000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1012697000.00
CPRX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -27000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 27286000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Leases: 991000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 2235000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2235000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 27286000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 1568000.00
CPRX cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -14574000.00
CPRX income_statement (quarterly, 2026-03-31) — Net Income: 63734000.00
CPRX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 63734000.00
CPRX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 63734000.00
CPRX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 63734000.00
CPRX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 63734000.00
CPRX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 63734000.00
CPRX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 63734000.00
CPRX income_statement (quarterly, 2026-03-31) — Net Interest Income: 6247000.00
CPRX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 6247000.00
CPRX cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1600000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Net PPE: 2852000.00
CPRX cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -27000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 890726000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 55111000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 55111000.00
CPRX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 78255000.00
CPRX income_statement (quarterly, 2026-03-31) — Normalized Income: 60139792.54
CPRX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 59587000.00
CPRX income_statement (quarterly, 2026-03-31) — Operating Income: 73232000.00
CPRX income_statement (quarterly, 2026-03-31) — Operating Revenue: 149390000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 122181308.00
CPRX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2718000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 745000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 8000.00
CPRX income_statement (quarterly, 2026-03-31) — Other Gand A: 13860000.00
CPRX income_statement (quarterly, 2026-03-31) — Other Income Expense: 4750000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 121971000.00
CPRX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -58000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 280000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Other Payable: 2432000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Other Properties: 1858000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Payables: 29209000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 124681000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 6526000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CPRX balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 15577000.00
CPRX income_statement (quarterly, 2026-03-31) — Pretax Income: 84229000.00
CPRX cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 3302000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CPRX cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -27000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Raw Materials: 16879000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Receivables: 131306000.00
CPRX income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 14405000.00
CPRX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 9773000.00
CPRX cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -14574000.00
CPRX income_statement (quarterly, 2026-03-31) — Research And Development: 2661000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 523349000.00
CPRX income_statement (quarterly, 2026-03-31) — Salaries And Wages: 5798000.00
CPRX income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 29661000.00
CPRX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 49319000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Share Issued: 122181308.00
CPRX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 6260000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1012697000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 890726000.00
CPRX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 1155792.54
CPRX income_statement (quarterly, 2026-03-31) — Tax Provision: 20495000.00
CPRX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.24
CPRX balance_sheet (quarterly, 2026-03-31) — Total Assets: 1147610000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1012697000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Total Debt: 2681000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1012697000.00
CPRX income_statement (quarterly, 2026-03-31) — Total Expenses: 76158000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 134913000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 207220000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2515000.00
CPRX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 73232000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 19626000.00
CPRX income_statement (quarterly, 2026-03-31) — Total Unusual Items: 4750000.00
CPRX income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 4750000.00
CPRX cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: -4750000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Work In Process: 2770000.00
CPRX balance_sheet (quarterly, 2026-03-31) — Working Capital: 807992000.00
CPS income_statement (annual, 2021-12-31) — Basic Average Shares: 17045353.00
CPS income_statement (annual, 2021-12-31) — Basic EPS: -18.94
CPS cash_flow (annual, 2021-12-31) — Common Stock Payments: 0.00
CPS income_statement (annual, 2021-12-31) — Diluted Average Shares: 17045353.00
CPS income_statement (annual, 2021-12-31) — Diluted EPS: -18.94
CPS cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 6741000.00
CPS cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 0.00
CPS cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 230000.00
CPS cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
CPS cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: 0.00
CPS income_statement (annual, 2021-12-31) — Salaries And Wages: 1279000.00
CPS income_statement (annual, 2021-12-31) — Write Off: 25609000.00
CPS income_statement (annual, 2022-12-31) — +Operating Expense: 206170000.00
CPS income_statement (annual, 2022-12-31) — +Total Revenue: 2525391000.00
CPS balance_sheet (annual, 2022-12-31) — Accounts Payable: 338210000.00
CPS balance_sheet (annual, 2022-12-31) — Accounts Receivable: 358700000.00
CPS balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -883131000.00
CPS balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 507498000.00
CPS balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -17193000.00
CPS income_statement (annual, 2022-12-31) — Amortization: 6715000.00
CPS cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 6715000.00
CPS cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 6715000.00
CPS income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 6715000.00
CPS cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 43710000.00
CPS income_statement (annual, 2022-12-31) — Basic Average Shares: 17190958.00
CPS income_statement (annual, 2022-12-31) — Basic EPS: -12.53
CPS cash_flow (annual, 2022-12-31) — Beginning Cash Position: 251128000.00
CPS balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 262694000.00
CPS cash_flow (annual, 2022-12-31) — Capital Expenditure: -71150000.00
CPS cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -71150000.00
CPS balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 98403000.00
CPS balance_sheet (annual, 2022-12-31) — Capital Stock: 17000.00
CPS balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 186875000.00
CPS balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 186875000.00
CPS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -4266000.00
CPS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -17892000.00
CPS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -36150000.00
CPS cash_flow (annual, 2022-12-31) — Change In Account Payable: 20591000.00
CPS cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 46177000.00
CPS cash_flow (annual, 2022-12-31) — Change In Inventory: -2221000.00
CPS cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -25739000.00
CPS cash_flow (annual, 2022-12-31) — Change In Payable: 20591000.00
CPS cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 66768000.00
CPS cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -5658000.00
CPS cash_flow (annual, 2022-12-31) — Change In Receivables: 2539000.00
CPS cash_flow (annual, 2022-12-31) — Change In Working Capital: 35689000.00
CPS cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -65712000.00
CPS cash_flow (annual, 2022-12-31) — Changes In Cash: -58308000.00
CPS balance_sheet (annual, 2022-12-31) — Common Stock: 17000.00
CPS balance_sheet (annual, 2022-12-31) — Common Stock Equity: 107713000.00
CPS balance_sheet (annual, 2022-12-31) — Construction In Progress: 76048000.00
CPS income_statement (annual, 2022-12-31) — Cost Of Revenue: 2395600000.00
CPS balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 218492000.00
CPS balance_sheet (annual, 2022-12-31) — Current Assets: 945649000.00
CPS balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 20786000.00
CPS balance_sheet (annual, 2022-12-31) — Current Debt: 54130000.00
CPS balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 74916000.00
CPS balance_sheet (annual, 2022-12-31) — Current Liabilities: 631618000.00
CPS cash_flow (annual, 2022-12-31) — Deferred Income Tax: 5653000.00
CPS cash_flow (annual, 2022-12-31) — Deferred Tax: 5653000.00
CPS cash_flow (annual, 2022-12-31) — Depreciation: 115761000.00
CPS cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 122476000.00
CPS income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 6715000.00
CPS cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 122476000.00
CPS income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 6715000.00
CPS income_statement (annual, 2022-12-31) — Diluted Average Shares: 17190958.00
CPS income_statement (annual, 2022-12-31) — Diluted EPS: -12.53
CPS income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -215384000.00
CPS income_statement (annual, 2022-12-31) — EBIT: -121986000.00
CPS income_statement (annual, 2022-12-31) — EBITDA: 490000.00
CPS income_statement (annual, 2022-12-31) — Earnings From Equity Interest: -8817000.00
CPS cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 12450000.00
CPS cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -13000.00
CPS balance_sheet (annual, 2022-12-31) — Employee Benefits: 129495000.00
CPS cash_flow (annual, 2022-12-31) — End Cash Position: 192807000.00
CPS cash_flow (annual, 2022-12-31) — Financing Cash Flow: -4266000.00
CPS balance_sheet (annual, 2022-12-31) — Finished Goods: 39202000.00
CPS cash_flow (annual, 2022-12-31) — Free Cash Flow: -107300000.00
CPS cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
CPS cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -33391000.00
CPS income_statement (annual, 2022-12-31) — Gain On Sale Of Business: -2257000.00
CPS income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 33391000.00
CPS income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -1131000.00
CPS balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -209971000.00
CPS income_statement (annual, 2022-12-31) — General And Administrative Expense: 199455000.00
CPS balance_sheet (annual, 2022-12-31) — Goodwill: 142023000.00
CPS balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 189664000.00
CPS balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 375893000.00
CPS balance_sheet (annual, 2022-12-31) — Gross PPE: 1620562000.00
CPS income_statement (annual, 2022-12-31) — Gross Profit: 129791000.00
CPS income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 43710000.00
CPS income_statement (annual, 2022-12-31) — Interest Expense: 78514000.00
CPS income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 78514000.00
CPS cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 80163000.00
CPS balance_sheet (annual, 2022-12-31) — Inventory: 157756000.00
CPS balance_sheet (annual, 2022-12-31) — Invested Capital: 1143897000.00
CPS cash_flow (annual, 2022-12-31) — Investing Cash Flow: -17892000.00
CPS cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CPS balance_sheet (annual, 2022-12-31) — Land And Improvements: 42939000.00
CPS balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 77617000.00
CPS balance_sheet (annual, 2022-12-31) — Long Term Debt: 982054000.00
CPS balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1059671000.00
CPS cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CPS cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -4178000.00
CPS balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1144310000.00
CPS balance_sheet (annual, 2022-12-31) — Minority Interest: -6521000.00
CPS income_statement (annual, 2022-12-31) — Minority Interests: 2407000.00
CPS cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
CPS balance_sheet (annual, 2022-12-31) — Net Debt: 849309000.00
CPS income_statement (annual, 2022-12-31) — Net Income: -215384000.00
CPS income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -215384000.00
CPS income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -217791000.00
CPS income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -215384000.00
CPS income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -215384000.00
CPS cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -217791000.00
CPS income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -217791000.00
CPS income_statement (annual, 2022-12-31) — Net Interest Income: -79224000.00
CPS cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -85000.00
CPS cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -4178000.00
CPS income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -79224000.00
CPS cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -4181000.00
CPS cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -30000.00
CPS balance_sheet (annual, 2022-12-31) — Net PPE: 737431000.00
CPS cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 53288000.00
CPS cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 4093000.00
CPS balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -81951000.00
CPS balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 19852000.00
CPS balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 7052000.00
CPS balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 19852000.00
CPS balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 7052000.00
CPS balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 129495000.00
CPS income_statement (annual, 2022-12-31) — Normalized EBITDA: 35183000.00
CPS income_statement (annual, 2022-12-31) — Normalized Income: -187976530.00
CPS cash_flow (annual, 2022-12-31) — Operating Cash Flow: -36150000.00
CPS cash_flow (annual, 2022-12-31) — Operating Gains Losses: -18259000.00
CPS income_statement (annual, 2022-12-31) — Operating Income: -76379000.00
CPS income_statement (annual, 2022-12-31) — Operating Revenue: 2525391000.00
CPS balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 17108029.00
CPS balance_sheet (annual, 2022-12-31) — Other Current Assets: 57113000.00
CPS balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 54130000.00
CPS balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -209971000.00
CPS income_statement (annual, 2022-12-31) — Other Gand A: 199455000.00
CPS income_statement (annual, 2022-12-31) — Other Income Expense: -44897000.00
CPS balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 47641000.00
CPS cash_flow (annual, 2022-12-31) — Other Non Cash Items: -10887000.00
CPS balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 70933000.00
CPS balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 34501000.00
CPS income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -1387000.00
CPS balance_sheet (annual, 2022-12-31) — Other Properties: 94571000.00
CPS balance_sheet (annual, 2022-12-31) — Other Receivables: 95965000.00
CPS income_statement (annual, 2022-12-31) — Other Special Charges: 2682000.00
CPS balance_sheet (annual, 2022-12-31) — Payables: 338210000.00
CPS balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 556702000.00
CPS cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 2682000.00
CPS balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CPS balance_sheet (annual, 2022-12-31) — Prepaid Assets: 31170000.00
CPS income_statement (annual, 2022-12-31) — Pretax Income: -200500000.00
CPS balance_sheet (annual, 2022-12-31) — Properties: 0.00
CPS balance_sheet (annual, 2022-12-31) — Raw Materials: 78033000.00
CPS balance_sheet (annual, 2022-12-31) — Receivables: 512735000.00
CPS income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 2279839000.00
CPS income_statement (annual, 2022-12-31) — Reconciled Depreciation: 122476000.00
CPS cash_flow (annual, 2022-12-31) — Repayment Of Debt: -4178000.00
CPS income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 18304000.00
CPS balance_sheet (annual, 2022-12-31) — Retained Earnings: -189831000.00
CPS income_statement (annual, 2022-12-31) — Salaries And Wages: 2682000.00
CPS cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
CPS cash_flow (annual, 2022-12-31) — Sale Of PPE: 53288000.00
CPS income_statement (annual, 2022-12-31) — Selling General And Administration: 199455000.00
CPS balance_sheet (annual, 2022-12-31) — Share Issued: 19173838.00
CPS income_statement (annual, 2022-12-31) — Special Income Charges: -33562000.00
CPS cash_flow (annual, 2022-12-31) — Stock Based Compensation: 3259000.00
CPS balance_sheet (annual, 2022-12-31) — Stockholders Equity: 107713000.00
CPS balance_sheet (annual, 2022-12-31) — Tangible Book Value: -81951000.00
CPS income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -7285530.00
CPS income_statement (annual, 2022-12-31) — Tax Provision: 17291000.00
CPS income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
CPS balance_sheet (annual, 2022-12-31) — Taxes Receivable: 58070000.00
CPS balance_sheet (annual, 2022-12-31) — Total Assets: 1963529000.00
CPS balance_sheet (annual, 2022-12-31) — Total Capitalization: 1089767000.00
CPS balance_sheet (annual, 2022-12-31) — Total Debt: 1134587000.00
CPS balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 101192000.00
CPS income_statement (annual, 2022-12-31) — Total Expenses: 2601770000.00
CPS balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1862337000.00
CPS balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1017880000.00
CPS balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1230719000.00
CPS income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -105002000.00
CPS income_statement (annual, 2022-12-31) — Total Other Finance Cost: 710000.00
CPS income_statement (annual, 2022-12-31) — Total Unusual Items: -34693000.00
CPS income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -34693000.00
CPS balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 2065809.00
CPS balance_sheet (annual, 2022-12-31) — Work In Process: 40521000.00
CPS balance_sheet (annual, 2022-12-31) — Working Capital: 314031000.00
CPS income_statement (annual, 2022-12-31) — Write Off: 43710000.00
CPS income_statement (annual, 2023-12-31) — +Operating Expense: 222545000.00
CPS income_statement (annual, 2023-12-31) — +Total Revenue: 2815879000.00
CPS balance_sheet (annual, 2023-12-31) — Accounts Payable: 334578000.00
CPS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 380562000.00
CPS balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -969907000.00
CPS balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 512164000.00
CPS balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -5944000.00
CPS income_statement (annual, 2023-12-31) — Amortization: 6804000.00
CPS cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 6804000.00
CPS cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 6804000.00
CPS income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 6804000.00
CPS cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 4768000.00
CPS income_statement (annual, 2023-12-31) — Basic Average Shares: 17355392.00
CPS income_statement (annual, 2023-12-31) — Basic EPS: -11.64
CPS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 192807000.00
CPS balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 270890000.00
CPS cash_flow (annual, 2023-12-31) — Capital Expenditure: -80743000.00
CPS cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -80743000.00
CPS balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 95059000.00
CPS balance_sheet (annual, 2023-12-31) — Capital Stock: 17000.00
CPS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 154801000.00
CPS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 154801000.00
CPS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -81137000.00
CPS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -64968000.00
CPS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 117277000.00
CPS cash_flow (annual, 2023-12-31) — Change In Account Payable: 6743000.00
CPS cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 16924000.00
CPS cash_flow (annual, 2023-12-31) — Change In Inventory: 6412000.00
CPS cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 20718000.00
CPS cash_flow (annual, 2023-12-31) — Change In Payable: 6743000.00
CPS cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 23667000.00
CPS cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 2924000.00
CPS cash_flow (annual, 2023-12-31) — Change In Receivables: -9730000.00
CPS cash_flow (annual, 2023-12-31) — Change In Working Capital: 43991000.00
CPS cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -12333000.00
CPS cash_flow (annual, 2023-12-31) — Changes In Cash: -28828000.00
CPS balance_sheet (annual, 2023-12-31) — Common Stock: 17000.00
CPS balance_sheet (annual, 2023-12-31) — Common Stock Equity: -81300000.00
CPS balance_sheet (annual, 2023-12-31) — Construction In Progress: 71706000.00
CPS income_statement (annual, 2023-12-31) — Cost Of Revenue: 2525103000.00
CPS balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 249376000.00
CPS balance_sheet (annual, 2023-12-31) — Current Assets: 900586000.00
CPS balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 18577000.00
CPS balance_sheet (annual, 2023-12-31) — Current Debt: 50712000.00